Not being able to turn off Send optional diagnostic data settings undermines our privacy and control and can be really frustrating. This issue often occurs when system policies, background services, ...

A health care company that previously announced big plans for expansion and hiring at its Birmingham headquarters is now shutting down. Pack Health, which was founded in Birmingham in 2013 and later ...

A second community diagnostics centre is being planned for the centre of Plymouth. University Hospitals Plymouth NHS Trust said it was "working on a business case" for another centre, similar to the ...

Figure 1 depicts the ways in which implicit bias (including stereotypes) that leads to false assumptions about an individual patient, combined with inattention to systemic and structural factors ...

With the most comprehensive Epic integration by a laboratory provider, collaboration will streamline and strengthen the customer experience for health systems, hospitals, independent providers and ...

The cases of H3N2 flu have been reported in Delhi and other NCR cities. A recent survey said that nearly 69% of households in Delhi-NCR have reported at least one member down with flu-like illness ...

AST Revolution, LLC (AST Revolution) today announced its official launch following the recent completion of a court-approved acquisition of select assets of Accelerate Diagnostics, Inc. (Accelerate) ...

A new £11.7m diagnostic centre that will "take the pressure off" a county's hospitals has been officially opened. The Corby Community Diagnostic Centre (CDC) at the Willowbrook Health Centre site will ...

Quest Diagnostics is launching a new pharmacogenomics program designed to decode patients’ DNA to predict how they will respond to certain therapies and doses. The company said its test will span ...

Dutch private equity firm Waterland has agreed to buy a majority stake in Cruinn Diagnostics, a leading independent laboratory equipment supplier in the Republic of Ireland. The deal values the ...

The Gulf region is undergoing a rapid transformation in healthcare, with major investments in infrastructure and a growing demand for accessible, innovative diagnostic solutions. Across eight cluster ...

The FDA approved the Oncomine Dx Target Test for identifying HER2-mutant NSCLC patients eligible for Hernexeos, an oral tyrosine kinase inhibitor. Hernexeos offers a new treatment option for ...